Ryman Healthcare's share price has gone up for the first half of July, leading experts to speculate about the company's future.
This follows a downturn from earlier in the year.
Milford Asset Management's Jeremy Hutton explains further.
LISTEN ABOVE

Enda Brady: UK correspondent on Donald Trump claiming he's 'not happy' with the UK's response to Middle East conflict
04:47

Paul Bloxham: HSBC chief economist on the RBA increasing the OCR for the second month in a row
05:53

Jamie Mackay: The Country host on the impacts of the Middle East conflict on the dairy sector
04:23